Skip to main content

#153328

HM3 Cell Line

Cat. #153328

HM3 Cell Line

Cat. #: 153328

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Human

Tissue: Kidney

Disease: Cancer

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Simon Cook

Institute: Babraham Institute

Tool Details
Target Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: HM3 Cell Line
  • Alternate name: Mitogen-activated protein kinase kinase kinase 3, MAPK/ERK kinase kinase 3, MEK kinase 3, MEKK 3
  • Research fields: Apoptosis and autophagy;Cancer;Cell biology;Cell signaling and signal transduction;Immunology
  • Tool sub type: Continuous
  • Parental cell: HEK 293
  • Organism: Human
  • Tissue: Kidney
  • Disease: Cancer
  • Growth properties: Adherent cell line
  • Conditional: Yes
  • Conditional description: Stable transfectant, conditional functionality: MEKK3 kinase activity and ERK1/2, JNK and p38 signalling pathways activated following 4-hydroxytamoxifen (4-HT) treatment of cells.
  • Description: HM3 cells are HEK 293 cells stably expressing conditional kinase ∆MEKK3:ER* from the pBabePuro plasmid. ∆MEKK3:ER* consists of the isolated kinase domain of MEKK3 fused in-frame to a modified form of the hormone binding domain of the estrogen receptor (hbER*) that can be de-repressed by 4-hydroxytamoxifen (4-HT) but not β-estradiol. In this case the * refers to a point mutation that ablates estradiol binding but allows 4-HT binding. Activation of ∆MEKK3:ER* leads to the strong activation of the JNK and p38 pathways and a weaker activation of ERK1/2. This cell line can be used to study the role and factors impacting on the JNK, p38 and ERK1/2 signalling pathways such as gene expression, cell proliferation, cell cycle arrest and cell death.. The cells are puromycin resistant. Conditional kinase activation of ∆MEKK3:ER* can be induced with 100nM 4-HT.
  • Production details: HEK 293 cells were transfected with the pBabePuro plasmid expressing â?‚ˆ?‚†MEKK3:ER*. Stable transfectants were selected using puromycin and ring cloning.
  • Cellosaurus id: CVCL_0306

Target Details

  • Target: MEKK3

Handling

  • Format: Frozen
  • Growth medium: Phenol red-free Dulbecco's modified Eagle's medium (DMEM) high glucose version, 2 mM L-glutamine, 10% fetal bovine serum (FBS), 2 ?g/ml puromycin.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: HR1 Cell Line

References

  • Gilley et al. 2009. Cell Signal. 21(6):969-77. PMID: 19249353.
  • ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos.
  • Boughan et al. 2006. J Biol Chem. 281(17):11637-48. PMID: 16513653.
  • Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection.
  • Todd et al. 2004. Oncogene. 23(19):3284-95. PMID: 14981547.
  • ERK1/2 and p38 cooperate to induce a p21CIP...

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.